Sensorion Declares Completion of Enrollment of First Cohort of Audiogene Section 1/2 Gene Remedy Medical Trial by Investing.com
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory information: Sensorion (FR0012596468 “ALSEN) a pioneering clinical-stage biotechnology firm…
